Toggle navigation
Home
Search
Services
Blog
Contact
About
Early Therapeutics Development with Phase II Emphasis
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
University of Medicine & Dentistry of NJ
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Massachusetts Comprehensive Asthma Control Program
Traumatic Brain Injury Clinical Trials Network-DCC
Biomedical Research Support
General Multidisciplinary Child Mental Health Training
Mortality Study of Airplane Maintenance Workers
Recently added grants:
Project 2: Particle and brain mapping of CSF proteins using elemental reporters with mass spectrometry
Ultrapotent Inhibitors of Wild-type and Multi-drug Resistant HIV
Project 3: Development of multiplex assays for clinical monitoring of disease
Project 4: Novel reagent development to enable molecular characterization
A Phase II Controlled Trial of Allogeneic Mesenchymal Stem Cells for the Treatment of Refractory Lupus
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CM62201-5-0-2
Application #
7568588
Study Section
Project Start
2006-01-01
Project End
2008-12-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 CA
Early Therapeutics Development with Phase II Emphasis
/ University of Chicago
$662,981
NIH 2007
N01 CA
Early Therapeutics Development with Phase II Emphasis
Vokes, Everett E. /
$1,737,296
NIH 2007
N01 CA
Early Therapeutics Development with Phase II Emphasis
/
$1,737,296
NIH 2007
N01 CA
Early Therapeutics Development with Phase II Emphasis
/
Comments
Be the first to comment on this grant